implemented in all cases of fetal anomalies, discussions arise on which fetuses should be referred for broad genetic testing. The diagnostic yield is highest in fetal cases with multiple congenital anomalies. Therefore, recently Lord and et al 1 suggested that WES is best performed by targeting those groups, in which it is most likely to be diagnostic, allowing a high diagnostic yield. We do agree that these cases have a clear indication for WES, which will lead to a diagnosis in 15.4%, as shown by Lord et al (2019) . This is important knowledge for the parents and relevant information for assessment of the recurrence risk. However, in many of such cases, a prenatal genetic diagnosis does not add significantly to decisions on pregnancy management. Eg, in case of a fetus with short extremities, a narrow thorax and polydactyly, the molecular diagnosis Ellis Van Creveld syndrome does neither change the fetal prognosis, nor perinatal management of the pregnancy. This is also supported by the paper of Lord et al, since 20/52 (38.5%) diagnoses were made in pregnancies that were terminated based solely on the ultrasound abnormalities. We think that the detection of genetic variants as a syndromic cause of fetal anomalies may be especially valuable in prenatal cases with a less severe phenotype or cases with an apparently isolated anomaly, in which a molecular diagnosis has a larger impact on decision-making during pregnancy or neonatal management. In As advised by the guidelines of the ISPD 2018, 3 we still offer WES in selected prenatal cases in the setting of a multidisciplinary team. However, we anticipate that, similar to microarray, prenatal WES soon will be routinely offered in all cases with ultrasound anomalies that undergo invasive sampling. Pretest and especially posttest counseling are of vital importance as it should be noted that where a normal result of WES in case of a "mild" prenatal phenotype is reassuring for prospective parents, one can never exclude the presence of an underlying syndrome. After all, not all pathogenic variants can be detected by WES and some of the variants cannot be classified as (likely) pathogenic in the absence of the postnatal phenotype.
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